B. Metzler seel. Sohn & Co’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
VCM
VPM
B. Metzler seel. Sohn & Co's IDXX Position: Q1 2026 in Review
B. Metzler seel. Sohn & Co reduced its Idexx Laboratories (IDXX) stake by 0.82% in Q1 2026, selling an estimated $85.9K and leaving 16,242 shares worth $9.13M. The position accounts for 0.08% of the portfolio, ranked #132.
B. Metzler seel. Sohn & Co first reported a position in IDXX in Q4 2020 and has held it in 22 quarters since. The position peaked at $11.4M in Q2 2025. 1,314 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- B. Metzler seel. Sohn & Co held 16,242 shares of Idexx Laboratories worth $9.13M as of Q1 2026.
- B. Metzler seel. Sohn & Co sold 134 Idexx Laboratories shares in Q1 2026, an estimated $85.9K.
- Idexx Laboratories made up 0.08% of B. Metzler seel. Sohn & Co's portfolio in Q1 2026, its #132 holding.
- B. Metzler seel. Sohn & Co first reported a position in Idexx Laboratories in Q4 2020 and has held it in 22 quarters since.
- B. Metzler seel. Sohn & Co's Idexx Laboratories position peaked at $11.4M in Q2 2025.
- 1,314 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on B. Metzler seel. Sohn & Co's 13F filing for Q1 2026, filed 8 May 2026.